CBMT11074 / NMDP 10-CBA / Omar Aljitawi, MBBS (previous PI-Jane Liesveld, MD)
Research Question:
What is the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation
in a multi-institution setting using CBUs that are not Food and Drug Administration
(FDA) licensed?
Basic Study Information
Purpose:
This study is an access and distribution protocol for unlicensed cryopreserved cord
blood units (CBUs) in pediatric and adult patients with hematologic malignancies and
other indications.
Location: University of Rochester Medical Center
Study Reference #: CBMT11074-
Lead Researcher (Principal Investigator)
Lead Researcher:
Omar Aljitawi
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search